Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

The Second Xiangya Hospital of Central South University | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Hui Li began her academic journey with a strong interest in internal medicine, which laid the foundation for her later specialization. Her doctoral studies at Central South University equipped her with in-depth knowledge of the mechanisms of disease progression and clinical applications. These formative years shaped her scientific curiosity and commitment to advancing research that bridges clinical practice and basic science.

Professional Endeavors

Prof. Li currently serves as the Associate Director of the Institute of Anesthesiology at Central South University, where she has taken on leadership responsibilities in guiding both clinical and academic teams. She has successfully secured competitive national research funding and has consistently contributed to the advancement of anesthesiology and perioperative medicine. Her role also extends to mentoring young researchers and postgraduate students, thereby strengthening the academic environment of her institution.

Contributions And Research Focus

Her primary research focus revolves around perioperative organ protection and neuro immune regulation. Prof. Li has explored the underlying biological mechanisms that influence patient outcomes during and after surgery, with an emphasis on protecting vital organs from damage. Her work highlights the intricate interaction between the nervous and immune systems in the perioperative setting, contributing valuable insights to both anesthesiology and internal medicine.

Impact And Influence

Prof. Li has published extensively in reputable international journals, including contributions to highly respected platforms such as Nature Communications, Cell Death and Disease, and Cardiovascular Diabetology. Through these publications, her findings have gained global recognition and have provided new directions for clinical research. Her influence extends beyond her own institution, as her research is frequently cited and built upon by other scholars in the field.

Academic Cites

The scholarly impact of Prof. Li is evident in the citations her work has received in the global academic community. Her contributions are referenced in multiple studies across anesthesiology, immunology, and cardiovascular research. This academic visibility underscores the relevance and applicability of her research in interdisciplinary domains.

Legacy And Future Contributions

Prof. Li’s academic legacy lies in her ability to connect molecular insights with practical clinical applications. Her work on organ protection and neuro immune pathways not only advances the field of anesthesiology but also has broader implications for perioperative care and long term patient recovery. Looking ahead, her continued leadership and innovative studies are expected to shape future standards in patient safety, anesthesia practices, and translational medicine.

Conclusion

Prof. Hui Li stands as a distinguished academic whose career reflects dedication to clinical innovation and scientific excellence. With her leadership in anesthesiology, her significant body of research, and her growing academic influence, she continues to contribute meaningfully to both scientific advancement and medical practice. Her trajectory promises further breakthroughs that will enhance patient outcomes and inspire future generations of researchers.

Notable Publications

"Random forest algorithm for predicting postoperative hypotension in oral cancer resection and free flap reconstruction surgery"

Authors: Shuiting Zhang, Yanling Zhang, Xinyu Ouyang, Hui Li , Ruping Dai
Journal: Scientific Reports
Year: 2025

"Monocytes perturbation implicated in the association of stress hyperglycemia with postoperative poor prognosis in non-diabetic patients with Stanford type-A acute aortic dissection"

Authors: Shuai Zhao, Di Fu, Wei Luo, Wei-Yun Shen, Xue-Mei Miao, Jia-Ying Li, Jing-Ying Yu, Qian Zhao, Hui Li, Ru-Ping Dai
Journal: Cardiovascular Diabetology
Year: 2024

Yajie Liu | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Yajie Liu | Cardiac Imaging | Best Researcher Award

Peking University Shenzhen Hospital | China

Author Profile:

Scopus

Orcid

🌟Prof. Dr. Yajie Liu – A Pioneer in Radiation Oncology & Cancer Research Excellence

🎓 EARLY ACADEMIC PURSUITS

Dr. Yajie Liu began her medical journey with a Bachelor of Medicine (1985–1990) from Norman Bethune University of Medical Sciences. Driven by a deep interest in oncology, she completed her Master's degree in Oncology (1993–1996) from Harbin Medical University, followed by a prestigious Ph.D. in Oncology (1998–2001) at the Peking Union Medical College.

To expand her global medical perspective, she completed a Visiting Scholar Fellowship in Radiation Oncology at Chonnam National University Hospital in South Korea in 2010.

🏥 PROFESSIONAL ENDEAVORS

Dr. Liu's medical career spans over three decades of dedicated clinical service and leadership:

  • 1990–1992: Resident Physician, ENT, First Workers' Hospital of Liaohe Petroleum Exploration Bureau

  • 1992–1998: Resident & Attending Physician, Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University

  • 2001–2017: Progressed from Attending to Chief Physician and Deputy Director at Shenzhen People’s Hospital

  • 2017–Present: Chief Physician and Director, Department of Radiation Oncology, Peking University Shenzhen Hospital

Her ascent to leadership reflects a consistent trajectory of clinical excellence and patient-centered care in oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC IMAGING

Dr. Liu has led and co-led numerous research projects focused on:

  • Radiosensitization in Cancer Therapy

  • Hyperthermia and Serum Biomarkers

  • Radiation-Induced Brain Injury

  • Gene Assays for Breast Cancer Prognosis

  • Advanced Radiotherapy Strategies for Rectal and Colorectal Cancer

She has actively participated in national-level research, contributing to the Ministry of Science & Technology's high-impact projects on biomarkers and innovative radiotherapy techniques.

💡 RESEARCH FUNDING & PROJECT LEADERSHIP

As Principal Investigator (PI):

  • Shenzhen Science & Technology Bureau (4 Projects)

  • Shenzhen Health Commission (1 Project)

  • International Collaboration Grant (¥500K)

These funded projects demonstrate her innovative approach in blending clinical insight with technological advancement, especially in plasma therapy and hypoxic tumor sensitization.

🌐 PROFESSIONAL LEADERSHIP & ACADEMIC SERVICE

Dr. Liu holds key roles in multiple national and regional medical bodies:

  • Standing Committee Member, CRTOG

  • Committee Member, Radiotherapy Branch, Chinese Medical Doctor Association

  • Vice Chair, Lung Cancer Committee, Guangdong Women Doctors’ Association

  • Director, Radiotherapy Branch, Shenzhen Anti-Cancer Association

  • Council Member, Jiusan Society Shenzhen Chapter

Her positions reflect widespread recognition of her expertise and leadership in oncology.

📚 ACADEMIC CITES & COLLABORATIONS

While specific citation metrics are not provided here, Dr. Liu’s work on biomarkers, 21-gene assays, radiation injury, and colorectal cancer radiosensitization has contributed to national and international collaborations, significantly enriching the literature in radiation oncology.

🌍 IMPACT AND INFLUENCE

Dr. Liu's multidisciplinary research has influenced clinical protocols, improved patient outcomes, and inspired young oncologists across China. Her work on low-temperature plasma in radiosensitization reflects her commitment to cutting-edge translational oncology.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yajie Liu's legacy is marked by:

  • Pioneering radiotherapy techniques

  • Mentoring future oncology leaders

  • Driving forward international research collaborations

Her future direction is expected to focus on precision oncology, AI-guided radiotherapy planning, and expanding patient-centered cancer care models.

📑 NOTABLE PUBLICATIONS

"Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress"

Authors: M Yang, D Shi, J Lyu, Y Pan, Y Lyv, X Chen, Y Ouyang, Y Liu, Y Li, L Song
Journal: Redox Biology
Year: 2025

"X-ray-activated nanoscintillators integrated with tumor-associated neutrophils polarization for improved radiotherapy in metastatic colorectal cancer"

Authors: H Li, J Zeng, Q You, M Zhang, Y Shi, X Yang, W Gu, Y Liu, N Hu, Y Wang, X Chen, J Mu
Journal: Biomaterials
Year: 2025